Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
ON-TIME-3: paracetamol versus fentanyl in STEMI patients pretreated with crushed ticagrelor
NL-OMON44492Phase 4Active, not recruiting
- Sponsor
- Isala
- Start
- Feb 2018
- Modality
- Small Molecules, Orthosteric Ligands → Classical Binding Small Molecules → Small Molecules
- Countries
- 1
01
Overview
Phase 4, randomised, open-label trial in myocardial infarction (MI) comparing Crushed ticagrelor + paracetamol with Crushed ticagrelor + fentanyl (2 arms). Primary endpoints: Platelet reactivity units after primary PCI and High on-treatment platelet reactivity at T2. Started Feb 2018; status: active, not recruiting.
02
Drugs
acetaminophenfentanylticagrelor
03
Conditions
myocardial infarction (MI)
Beyond the preview
Go deeper on NL-OMON44492.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NL-OMON44492.